INSMED Inc·4

Feb 6, 4:18 PM ET

Flammer Martina M.D. 4

4 · INSMED Inc · Filed Feb 6, 2026

Research Summary

AI-generated summary of this filing

Updated

INSMED CMO Martina Flammer Sells 869 Shares

What Happened Dr. Martina Flammer, Chief Medical Officer of INSMED Inc. (INSM), sold 869 shares on 2026-02-05 at $152.44 per share, for gross proceeds of $132,470. The filing reports this as an open-market/private sale (Form 4 code S). Sales are often routine and do not necessarily signal a change in outlook.

Key Details

  • Transaction date and price: 2026-02-05 — 869 shares at $152.44 each.
  • Total value: $132,470 (gross proceeds).
  • Shares owned after transaction: not disclosed in the information provided in this summary.
  • Footnote: Transaction was executed under a pre-established Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2025.
  • Filing timeliness: Report filed 2026-02-06 for a 2026-02-05 transaction — filed promptly (timely).

Context A 10b5-1 plan lets insiders sell shares on a preset schedule and is commonly used to avoid trading on inside information; trades under such plans are typically considered less informative about the insider’s current view. For retail investors, purchases tend to carry more direct informational weight than routine sales; this filing alone does not indicate a change in company fundamentals.

Insider Transaction Report

Form 4
Period: 2026-02-05
Flammer Martina M.D.
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    [F1]
    2026-02-05$152.44/sh869$132,47083,243 total
Footnotes (1)
  • [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Signature
/s/ Martina Flammer, M.D., by Michael A. Smith as Attorney-in-fact|2026-02-06

Documents

1 file
  • 4
    wk-form4_1770412728.xmlPrimary

    FORM 4